Clinical Trial Update: Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chidamide maintenance in MRD-positive double-expressor diffuse large B-cell lymphoma patients in first complete remission; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Rong Tao | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING